Pharmaceutical Analysis, Drug Discovery and Designing Chemistry

Steinar Madsen is medical director at the Norwegian Medicines Agency. He has been working with the safe and cost-effective use of medicines for more than 20 years. He has been working with generics since 2000 and biosimilars since 2006. In 2001, generic substitution at pharmacy level was introduced in Norway. Dr. Madsen is a specialist in internal medicines and cardiology and works part time as a consultant in cardiology.